For the study, researchers led by Patrick Duffy of Seattle Biomedical Research Institute examined 565 women in Tanzania's Muheza district. The researchers found that 75 fetuses of women pregnant for the first time had two copies of the mutated gene. All of the 75 fetuses were delivered, according to the study. However, 10% of women pregnant for the first time whose fetuses did not have the mutated gene had a miscarriage. In addition, infants born without the mutation were twice as likely to be born underweight as those with the mutation.

According to Duffy, the mutated gene might reduce maternal inflammation and protect fetuses from contracting malaria during a woman's first pregnancy. After subsequent pregnancies, women develop antibody resistance to placental malaria, which might increase the survival chances for fetuses without the mutation. "This is the first resistance gene identified for any infectious disease that functions in (the womb)," Duffy said (ANI/Thaindian News, 9/9).

An abstract of the study is available online.

This article is republished with kind permission from our friends at The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is published for Kaisernetwork, a free service of The Henry J. Kaiser Family Foundation. 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.